Inventor
DE WAAL MALEFYT RENE
US40 patents
⚠️ This page may combine multiple inventors who share the name “DE WAAL MALEFYT RENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
21 patentsUS7090847B1Aug 15, 2006
Mammalian cytokines; related reagents and methods
SCHERING CORP69 citations96
US7183382B2Feb 27, 2007
Mammalian genes; related reagents and methods
SCHERING CORP50 citations94
US5837232ANov 17, 1998
Use of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorder
SCHERING CORP30 citations92
US7071308B2Jul 4, 2006
Cytokine receptor
SCHERING CORP13 citations91
US6890734B2May 10, 2005
Nucleic acids encoding a cytokine receptor complex
SCHERING CORP16 citations91
US6746670B2Jun 8, 2004
Regulatory T cells; methods
SCHERING CORP27 citations88
US6670146B2Dec 30, 2003
Regulatory T cells; methods
SCHERING CORP17 citations87
US7883695B2Feb 8, 2011
IL-12P40 and IL-B30 polypeptide complex
SCHERING CORP12 citations82
US5837293ANov 17, 1998
Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity
SCHERING CORP9 citations73
US7579440B2Aug 25, 2009
Mammalian cytokines; related reagents
SCHERING CORP5 citations72
US7569224B2Aug 4, 2009
Mammalian cytokines; receptors; related reagents and methods
SCHERING CORP5 citations72
US7148330B2Dec 12, 2006
Binding compounds for IL-27
SCHERING CORP5 citations72
US6797813B2Sep 28, 2004
AK155 antibodies and binding fragments thereof
SCHERING CORP6 citations68
US6319493B1Nov 20, 2001
Treatment of neoplastic disease with interleukin-10
SCHERING CORP3 citations60
US7122340B2Oct 17, 2006
Regulatory T cells; methods
SCHERING CORP3 citations57
US7445779B2Nov 4, 2008
Methods of modulating IFNy production
SCHERING CORP2 citations56
US7928198B2Apr 19, 2011
IL-B50 polypeptide
SCHERING CORP0 citations51
US7906622B2Mar 15, 2011
IL-D80 polypeptides and IL-27
SCHERING CORP0 citations51
US7491500B2Feb 17, 2009
Mammalian cytokine; related reagents
SCHERING CORP0 citations49
US7241438B2Jul 10, 2007
AK155 polypeptides
SCHERING CORP0 citations49
US6884410B1Apr 26, 2005
Methods for modulating antigen-specific immune responses
SCHERING CORP1 citations49
MERCK SHARP & DOHME
6 patentsUS10188730B2Jan 29, 2019
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME42 citations97
US11278620B2Mar 22, 2022
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME3 citations72
US10898571B2Jan 26, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME2 citations72
US11207406B2Dec 28, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME0 citations62
US11045547B2Jun 29, 2021
Anti-LAG3 antibodies and antigen-binding fragments
MERCK SHARP & DOHME0 citations62
US9732151B2Aug 15, 2017
Biomarkers for TSLP treatment
MERCK SHARP & DOHME0 citations47